Dry Eye Disease and Meibomian Gland Dysfunction: Imperfect Together

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Bausch + Lomb.

Activity Description

Meibomian gland dysfunction (MGD) is a leading cause for the development and progression of evaporative dry eye disease (DED). Evaporative DED results from a deficient tear film lipid layer causing increased tear evaporation. Dry eye disease is frequently misdiagnosed, especially in asymptomatic patients, resulting in undertreatment of disease. New and emerging therapies with novel mechanisms of action that manage the signs and symptoms of evaporative DED associated with MGD are being investigated. In this CE activity, experts in the field will review risk factors for DED associated with MGD that assist in its early detection and evaluate therapies for their efficacy and safety in disease management.

Target Audience

The intended audience for this activity is ophthalmologists, optometrists, and other healthcare professionals involved in the management of patients with, or at risk for, dry eye disease (DED) and Meibomian gland dysfunction (MGD).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Review the risk factors associated with the presence of meibomian gland dysfunction (MGD) with dry eye disease (DED) to assist in early identification and treatment.
• Examine therapies that have exhibited efficacy and safety in the treatment of DED associated with MGD.

Activity Chair

Preeya K. Gupta, MD
Managing Director
Triangle Eye Consultants
Raleigh, NC
Adjunct Associate Professor of Ophthalmology
Cornea, Cataract, & Refractive Surgery
Tulane University
New Orleans, LA

Faculty

Jennifer M. Loh, MD
Medical Director, Loh Ophthalmology Associates
Board Member, Eye Physicians of Florida
Clinical Faculty, Larkin Hospital Ophthalmology Residency
Miami, FL

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Kelly K. Nichols, OD, MPH, PhD, FAAO

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity will also award credit for optometry (COPE) if the requirements necessary for credit are met.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education designates this enduring activity for a maximum of 0.75 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.

COPE Course ID: 87736-TD
COPE Activity ID: 127074

This enduring material is approved for 1 year from the date of original release, October 31, 2023, to October 30, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 9 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or COPE CE certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Preeya K. Gupta, MD
Consultant: Alcon, Aldeyra, Allergan, Azura, Expert Opinion, HanAll, Johnson & Johnson Vision, Kala, New World Medical, Novartis, Ocular Science, Ocular Therapeutix, Orasis, Oyster Point, Sight Sciences, Spyglass, Surface, Sun, TearLab, TearClear, TissueTech, Visionology, Zeiss
Individual Stocks and Stock Options: Azura, Expert Opinion, Orasis, Oyster Point, Spyglass, Surface, Tarsus, TearClear, Visant, Visionology

Jennifer M. Loh, MD
Consultant: Alcon, Allergan, Bausch + Lomb, Centricity Vision, Horizon, Johnson & Johnson Vision, Kala, LENSAR, Novartis, Omeros, Orasis, OSRX, Sight Sciences, Sun, Tarsus, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon, Allergan, Kala, Sight Sciences, Sun
Independent Research Contractor: Sight Sciences
Individual Stocks and Stock Options: NovaBay

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Kelly K. Nichols, OD, MPH, PhD, FAAO
Consultant: AbbVie, Aerie, Alcon, Alderya, Allergan, Axim Biotech, Azura, Bausch + Lomb, Bruder, Dompe, HanAll Bio, Kala, Nicox, Novaliq, Novartis, Osmotica, Oyster Point, Palatin, RVL Pharmaceuticals, Shire, Takeda, Tarsus, TearSolutions, Thea, TopiVert, Trukera, Versea, Xequel Bio
Speaker Contracted by Ineligible Company: Bausch + Lomb
Individual Stocks and Stock Options: Axim, Oyster Point

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com